ResearcherIowa State UniversityActive in the last 2 years

Susheel Kumar Nethi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4138-1618; OpenAlex author ID A5074076072. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 2 papers

Papers 2

Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.1007/s40883-025-00394-0 ↗
Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. Co-author DOI 10.1016/j.isci.2025.114088 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Balaji Narasimhan · 2 shared papers, 2025 · strength 0.49
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088 ↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0 ↗
Brianna M. White · 2 shared papers, 2025 · strength 0.49
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088 ↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0 ↗
Venugopal Gunda · 2 shared papers, 2025 · strength 0.49
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088 ↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0 ↗
Nagabhishek Sirpu Natesh · 2 shared papers, 2025 · strength 0.49
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088 ↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0 ↗
Surinder K. Batra · 2 shared papers, 2025 · strength 0.49
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088 ↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0 ↗
Satyanarayana Rachagani · 2 shared papers, 2025 · strength 0.49
- Paper Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition. DOI 10.1016/j.isci.2025.114088 ↗
- Paper Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1007/s40883-025-00394-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.